ozone exposure may activate regulatory T cells to reduce chronic inflammation in autoimmune conditions
Ozone therapy in autoimmune diseases including multiple sclerosis, rheumatoid arthritis, and Crohn's disease shows encouraging results via autohemotherapy, potentially by activating regulatory T cells to downregulate chronic inflammation.
What this means for you
Regulatory T cells act like a volume dial on your immune system — when they're more active, runaway inflammation tends to quiet down. Early findings suggest ozone exposure may support this balancing response, which is relevant for anyone dealing with the kind of persistent, low-grade inflammation that affects energy, joint comfort, and overall resilience.
The published research
This page describes a documented finding about the underlying wellness technology. It is not a marketing claim about any specific device. For information about HOCATT specifically, visit hocatt.com.